Full Name
Gina Shishima
Job Title
Chief Strategy and Operations Partner, US
Court or Organization
Norton Rose Fulbright US LLP
Speaker Bio
Gina previously was the US Head of Intellectual Property at the firm, and prior to that, she led the US IP Transactions and Patent Prosecution practice. She has a Ph.D. in molecular biology, and because of her significant technical background, she greatly enjoys working with her clients in the areas of biotechnology, pharmaceuticals, and medical apparatuses to strategize and provide business solutions related to all aspects of patent law—particularly prosecution, post-grant challenges, litigation and due diligence. Her clients include public and private life sciences companies, as well as hospitals and universities. Her expertise includes patent portfolio management and patent counseling, as well as involvement in inter partes reviews (IPR), reexaminations, interferences, and European oppositions. Other experience includes a wide variety of involvement in patent litigation matters and licensing issues. In addition, Gina has experience in patentability opinions, freedom to operate evaluations, intellectual property due diligence and competitive technology assessments.
In the course of her patent litigation and prosecution work, Gina has worked on a variety of therapeutic and diagnostic areas in biotechnology and pharmaceutics such as: nucleic acid and peptide/protein therapies, antibody- and cell-based immunotherapies, vaccines, gene therapy, virus applications, stem cells, biomarker assays, microbiome applications, small molecule treatments, drug formulations and delivery systems, drug screening and drug development platforms, molecular biology reagents, and pharmacogenomics (personalized medicine) in a wide variety of indications (for example, cancer, bacterial and viral infections, genetic diseases, autoimmune diseases, diabetes, neurological disorders, and cardiovascular diseases and conditions). In addition, her litigation, due diligence, and prosecution experience extends into the areas of medical devices and apparatuses.
Gina is a member of the US Management and the Global Executive Committees.
Education
JD, School of Law at University of California, Berkeley, 1998
Ph.D, Molecular Biology, Princeton University, 1995
AB, Biochemistry, Columbia University, 1989
While attending UC Berkeley School of Law, Gina was a member of the California Law Review and an associate editor for the Berkeley Technology Law Journal. She is a member of the Texas and New York bars and admitted to practice in the Western and Eastern Districts of Texas, the Southern and Eastern Districts of New York, and the Court of Appeals for the Federal Circuit. She is registered to practice before the United States Patent and Trademark Office.
Admissions
New York State Bar
Texas State Bar
US Patent and Trademark Attorney
In the course of her patent litigation and prosecution work, Gina has worked on a variety of therapeutic and diagnostic areas in biotechnology and pharmaceutics such as: nucleic acid and peptide/protein therapies, antibody- and cell-based immunotherapies, vaccines, gene therapy, virus applications, stem cells, biomarker assays, microbiome applications, small molecule treatments, drug formulations and delivery systems, drug screening and drug development platforms, molecular biology reagents, and pharmacogenomics (personalized medicine) in a wide variety of indications (for example, cancer, bacterial and viral infections, genetic diseases, autoimmune diseases, diabetes, neurological disorders, and cardiovascular diseases and conditions). In addition, her litigation, due diligence, and prosecution experience extends into the areas of medical devices and apparatuses.
Gina is a member of the US Management and the Global Executive Committees.
Education
JD, School of Law at University of California, Berkeley, 1998
Ph.D, Molecular Biology, Princeton University, 1995
AB, Biochemistry, Columbia University, 1989
While attending UC Berkeley School of Law, Gina was a member of the California Law Review and an associate editor for the Berkeley Technology Law Journal. She is a member of the Texas and New York bars and admitted to practice in the Western and Eastern Districts of Texas, the Southern and Eastern Districts of New York, and the Court of Appeals for the Federal Circuit. She is registered to practice before the United States Patent and Trademark Office.
Admissions
New York State Bar
Texas State Bar
US Patent and Trademark Attorney
Speaking At
